CA1339958C - Isoferritine, marqueur pour grossesse pathologique - Google Patents

Isoferritine, marqueur pour grossesse pathologique

Info

Publication number
CA1339958C
CA1339958C CA000595762A CA595762A CA1339958C CA 1339958 C CA1339958 C CA 1339958C CA 000595762 A CA000595762 A CA 000595762A CA 595762 A CA595762 A CA 595762A CA 1339958 C CA1339958 C CA 1339958C
Authority
CA
Canada
Prior art keywords
plf
antibody
pregnancy
molecule
ferritin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000595762A
Other languages
English (en)
Inventor
Chaya Moroz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/210,601 external-priority patent/US4954434A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1339958C publication Critical patent/CA1339958C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000595762A 1988-04-08 1989-04-05 Isoferritine, marqueur pour grossesse pathologique Expired - Fee Related CA1339958C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17918388A 1988-04-08 1988-04-08
US07/179,183 1988-04-08
US07/210,601 US4954434A (en) 1981-05-15 1988-06-23 Isoferritin as a marker for pathological pregnancy
US07/210,601 1988-06-23

Publications (1)

Publication Number Publication Date
CA1339958C true CA1339958C (fr) 1998-07-21

Family

ID=26875089

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000595762A Expired - Fee Related CA1339958C (fr) 1988-04-08 1989-04-05 Isoferritine, marqueur pour grossesse pathologique

Country Status (4)

Country Link
EP (1) EP0408651A4 (fr)
JP (1) JPH03504640A (fr)
CA (1) CA1339958C (fr)
WO (1) WO1989009936A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107106588A (zh) * 2014-10-28 2017-08-29 山口晃史 用于改善妊娠状态的药剂及其使用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126181A0 (en) * 1998-09-11 1999-05-09 Univ Ramot Dna sequences proteins coded by them medicaments and detection methods using same
US7217686B1 (en) 1999-09-08 2007-05-15 Gardino Investment N.V. DNA sequence encoding oncofetal ferritin protein
US11541040B2 (en) 2014-10-28 2023-01-03 Kouchi Yamaguchi Medicine for improving state of pregnancy, and use thereof
CN114047336B (zh) * 2021-12-13 2024-10-29 大连医科大学 一种用于辅助诊断复发性流产的生物标志物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748657C3 (de) * 1977-10-29 1980-08-07 Hoechst Ag, 6000 Frankfurt Verfahren zur Bestimmung von Ferritin
IL62879A (en) * 1981-05-15 1985-09-29 Chaya Moroz Monoclonal antibodies,clones producing them,preparation of such antibodies and clones and cytotoxic and immunoassay using such antibodies
US4531046A (en) * 1983-01-10 1985-07-23 Bunn-O-Matic Corporation Beverage brewing apparatus with constant temperature water reservoir
ATE153765T1 (de) * 1988-03-07 1997-06-15 S Leslie Misrock Plazentale isoferritine zur prognose und diagnose zur immunosuppression

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107106588A (zh) * 2014-10-28 2017-08-29 山口晃史 用于改善妊娠状态的药剂及其使用

Also Published As

Publication number Publication date
EP0408651A1 (fr) 1991-01-23
EP0408651A4 (en) 1991-12-27
JPH03504640A (ja) 1991-10-09
WO1989009936A1 (fr) 1989-10-19

Similar Documents

Publication Publication Date Title
US4954434A (en) Isoferritin as a marker for pathological pregnancy
EP0447424B1 (fr) Procede servant a isoler des cellules fetales du sang maternel en vue d'un diagnostic prenatal
TAYLOR et al. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block
CN102037359B (zh) 吞噬细胞的功能评价方法
WO1992010585A1 (fr) Reactifs et kits de determination d'antigenes fetaux restreints
EP0674661B1 (fr) Titrage et traitement destines aux maladies demyelinisantes telles que la sclerose en plaques
US4746539A (en) Purification of cancer-associated protein and preparation of antibody thereto
Vyas et al. Lmmunobiology of human anti‐lgA: a serologic and immunogenetic study of immunization to IgA in transfusion and pregnancy
Thorsby et al. HL-A Antigens and Genes-III. Production of HL-A Typing Antisera of Desired Specificity
WO1989009936A1 (fr) Isoferritine comme marqueur de grossesse pathologique
Tedesco et al. Prevalence and biological effects of anti‐trophoblast and anti‐endothelial cell antibodies in patients with recurrent spontaneous abortions
JPS63500797A (ja) 崩壊加速因子に対するモノクロ−ン抗体、その生成方法および使用
EP0554458A1 (fr) Dosage immunologique, anticorps monoclonal et hybridome
EP0145373B1 (fr) Purification d'une protéine associée au cancer et préparation d'anticorps contre cette protéine
US6767709B1 (en) Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same
Mecheri et al. Immunogenic Ia-binding peptides immobilize the Ia molecule and facilitate its aggregation on the B cell membrane. Control by the M1s-1 gene.
Kaplan et al. Maternal thrombocytopenia during pregnancy: Diagnosis and etiology
US4743538A (en) Test for rheumatic fever and monoclonal antibodies useful therefor
AU621694B2 (en) Isolation of fetal cells from maternal blood to enable prenatal diagnosis
JP2580028B2 (ja) 抗ひと精子抗体、その製法および用途
JPH0219768A (ja) ヒトアデノシンデアミナーゼの免疫学的測定方法
JPH0823969A (ja) ブルーム症候群患者由来のｂリンパ細胞株から誘導された流産関連胎児抗原性を有する細胞クローンならびにそれらの細胞膜蛋白を用いた妊娠早期流産患者血清中流産関連胎児抗体測定による診断法ならびに流産治療薬
JPH03504272A (ja) 免疫抑制の予知および診断のための胎盤イソフェリチン
JPH0975089A (ja) 流産関連胎児性抗原遺伝子、その抗原決定基を含む合成ペプチドおよびその製造方法並びに用途
JPH06225787A (ja) 下痢性貝毒特異的モノクローナル抗体、ハイブリドーマ及び下痢性貝毒検出方法

Legal Events

Date Code Title Description
MKLA Lapsed
MKLA Lapsed

Effective date: 20010723